Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Identification of the A?37/42 peptide ratio in CSF as an improved A? biomarker for Alzheimer's disease.
Oleic Acid
Preoperative Duration of Symptoms Does Not Affect Outcomes of Anterior Lumbar Interbody Fusion.
Uricosuric Agents
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Identification of the A?37/42 peptide ratio in CSF as an improved A? biomarker for Alzheimer's disease.
Identification of the A?37/42 peptide ratio in CSF as an improved A? biomarker for Alzheimer's disease. Alzheimers Dement. 2023 01; 19(1):79-96.
View in:
PubMed
subject areas
Alzheimer Disease
Amyloid beta-Peptides
Amyloid Precursor Protein Secretases
Biomarkers
Cognitive Dysfunction
Humans
Peptide Fragments
tau Proteins
authors with profiles
David Bennett